RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2025.10.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Rezvan Parvizi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA; Department of Molecular and Systems Biology, Geisel …. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Core Binding Factor Alpha 2 Subunit, Fibroblasts, Skin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of General Medical Sciences.
Abstract (Originalsprache)
OBJECTIVES: The activation of runt-related transcription factor 1 (RUNX1) in fibroblasts has been implicated in wound healing and fibrosis; however, the role of RUNX1 in the fibrotic progression of the autoimmune disease systemic sclerosis (SSc) remains known. METHODS: Leveraging gene expression, genome-wide DNA methylation, and single-cell resolution data of SSc skin and fibroblast, we analysed the impact of RUNX1 dysregulation in SSc dermal fibrosis. RUNX1 function was subsequently assessed using siRNA, pharmacologic inhibition, and CRISPR knockout in 2-dimensional and 3-dimensional fibroblast cultures. RESULTS: Analysis of gene expression in multiple cohorts demonstrated an association between the severity of dermal fibrosis and the expression levels of RUNX1 in the skin of patients with SSc. Epigenomic analyses of methylation identified hypomethylated 5-Cytosine-phosphate-Guanine-3 (CpG) sites proximal to the RUNX1 gene, implicating their potential role in the increased expression of RUNX1. Analysis of single-cell RNA-seq data from skin biopsies of individuals with SSc revealed that RUNX1 is higher in subpopulations of fibroblasts enriched in SSc, which are believed to contribute to fibrosis. RUNX1 CRISPR knockout resulted in reduced alpha smooth muscle actin expression. Inhibition of RUNX1 activity caused a reduction in fibroblast activation, contraction, extracellular matrix components, and proliferation rates, including a reduction in SFRP4, LUM, and COL1A1. CONCLUSIONS: This study is the first to demonstrate a potential role for RUNX1 in the pathogenesis of SSc dermal fibrosis. RUNX1 is associated with more severe SSc fibrosis and is associated with a subpopulation of dermal fibroblasts implicated in fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
- Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
- Department of Basic and Clinical Translational Sciences, Tufts University School of Dental Medicine, Boston, MA, USA.
- Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
- Department of Dermatology, University of Michigan, Ann Arbor, MI, USA; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
- Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of General Medical Sciences
- National Institutes of Health
- National Institutes of Health National Cancer Institute
- National Scleroderma Foundation
- Scleroderma Research Foundation
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Parvizi, R., Gong, Z., Jarnagin, H. C., Toledo, D. M., Abel, T. R., Popovich, D., Morrisson, M. J., Wood, T. A., Shenk, S., Sarkar, M. K., Plazyo, O., Dey, P., Coon, A., Erba, J. M., Tsoi, L. C., Tsou, P. S., Hinchcliff, M. E., Khanna, D., Garlick, J. A., …, & Whitfield, M. L. (2026). RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.10.033
Vancouver
Parvizi R, Gong Z, Jarnagin HC, Toledo DM, Abel TR, Popovich D, et al. RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.10.033
BibTeX
@article{Parvizi2026,
author = {Parvizi, Rezvan and Gong, Zhiyun and Jarnagin, Helen C and Toledo, Diana M and Abel, Tamar R and Popovich, Dillon and Morrisson, Madeline J and Wood, Tammara A and Shenk, Sasha and Sarkar, Mrinal K and Plazyo, Olesya and Dey, Poulami and Coon, Anthony and Erba, Jake M and Tsoi, Lam C and Tsou, Pei-Suen and Hinchcliff, Monique E and Khanna, Dinesh and Garlick, Jonathan A and Gudjonsson, Johann E and Pioli, Patricia A and Whitfield, Michael L},
title = {RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2025.10.033}
}
EUVIMED